These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Transport properties and aggregation phenomena of polyoxyethylene sorbitane monooleate (polysorbate 80) in pig gastrointestinal mucin and mucus. Lafitte G; Thuresson K; Jarwoll P; Nydén M Langmuir; 2007 Oct; 23(22):10933-9. PubMed ID: 17894509 [TBL] [Abstract][Full Text] [Related]
49. Nanoparticles decorated with proteolytic enzymes, a promising strategy to overcome the mucus barrier. Pereira de Sousa I; Cattoz B; Wilcox MD; Griffiths PC; Dalgliesh R; Rogers S; Bernkop-Schnürch A Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):257-64. PubMed ID: 25661320 [TBL] [Abstract][Full Text] [Related]
50. Mucin-mediated nanocarrier disassembly for triggered uptake of oligonucleotides as a delivery strategy for the potential treatment of mucosal tumours. Martirosyan A; Olesen MJ; Fenton RA; Kjems J; Howard KA Nanoscale; 2016 Jul; 8(25):12599-607. PubMed ID: 26694897 [TBL] [Abstract][Full Text] [Related]
51. From mucins to mucus: toward a more coherent understanding of this essential barrier. Thornton DJ; Sheehan JK Proc Am Thorac Soc; 2004; 1(1):54-61. PubMed ID: 16113413 [TBL] [Abstract][Full Text] [Related]
52. Several Sterilization Strategies Maintain the Functionality of Mucin Glycoproteins. Rickert CA; Lutz TM; Marczynski M; Lieleg O Macromol Biosci; 2020 Jul; 20(7):e2000090. PubMed ID: 32431054 [TBL] [Abstract][Full Text] [Related]
53. Physicochemical properties of mucus and their impact on transmucosal drug delivery. Leal J; Smyth HDC; Ghosh D Int J Pharm; 2017 Oct; 532(1):555-572. PubMed ID: 28917986 [TBL] [Abstract][Full Text] [Related]
54. Mucins: a biologically relevant glycan barrier in mucosal protection. Corfield AP Biochim Biophys Acta; 2015 Jan; 1850(1):236-52. PubMed ID: 24821013 [TBL] [Abstract][Full Text] [Related]
55. Hagfish slime and mucin flow properties and their implications for defense. Böni L; Fischer P; Böcker L; Kuster S; Rühs PA Sci Rep; 2016 Jul; 6():30371. PubMed ID: 27460842 [TBL] [Abstract][Full Text] [Related]
56. Mucin structure. The structure and heterogeneity of respiratory mucus glycoproteins. Sheehan JK; Thornton DJ; Somerville M; Carlstedt I Am Rev Respir Dis; 1991 Sep; 144(3 Pt 2):S4-9. PubMed ID: 1892325 [TBL] [Abstract][Full Text] [Related]
57. Atomic force microscopy of the submolecular architecture of hydrated ocular mucins. McMaster TJ; Berry M; Corfield AP; Miles MJ Biophys J; 1999 Jul; 77(1):533-41. PubMed ID: 10388778 [TBL] [Abstract][Full Text] [Related]
58. Gel-forming mucins. Notions from in vitro studies. Perez-Vilar J; Mabolo R Histol Histopathol; 2007 Apr; 22(4):455-64. PubMed ID: 17290356 [TBL] [Abstract][Full Text] [Related]
59. Transient binding promotes molecule penetration into mucin hydrogels by enhancing molecular partitioning. Marczynski M; Käsdorf BT; Altaner B; Wenzler A; Gerland U; Lieleg O Biomater Sci; 2018 Nov; 6(12):3373-3387. PubMed ID: 30362469 [TBL] [Abstract][Full Text] [Related]
60. The levels of Brachyspira hyodysenteriae binding to porcine colonic mucins differ between individuals, and binding is increased to mucins from infected pigs with de novo MUC5AC synthesis. Quintana-Hayashi MP; Mahu M; De Pauw N; Boyen F; Pasmans F; Martel A; Premaratne P; Fernandez HR; Teymournejad O; Vande Maele L; Haesebrouck F; Lindén SK Infect Immun; 2015 Apr; 83(4):1610-9. PubMed ID: 25644008 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]